Home Vigil Neuroscience

Vigil Neuroscience

acquired
IPO Delisting
Neurodegenerative Disease Treatment New Drug Developer
Basic
Enterprise Profile

Basic Information

Vigil Neuroscience is discovering and developing new therapies based on breakthroughs in microglial basic science and human genetics, treating rare and common neurodegenerative diseases by restoring the vigilance of microglia (the sentinel cells of the brain's immune system). We are leveraging modern neuroscience drug development tools to rapidly deliver precision-based treatments to improve the lives of patients and their families.
Vigil Neuroscience, Inc.
Cambridge,Massachusetts,United States of America
less than 15 people
January 01, 2020
info@vigilneuro.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Biological Pharmaceutical Products
Technology
Biotechnology
Concept
Neurosurgery # Brain Sciences Therapeutic Products
Application Scenarios
Innovative Drugs Monoclonal Antibody